Inflammatory response pathway modulation (null)

The inflammatory response pathway encompasses the network of signaling events that govern the body’s response to harmful stimuli, including activation of transcription factors such as NF-κB, STAT proteins, and AP-1, as well as key receptors. Modulation of this pathway represents a therapeutic paradigm that targets crucial mediators—including cytokines (IL-1β, TNF-α, IL-6), inflammasome components (NLRP3, caspase-1), and their downstream effectors—to control acute and chronic inflammation. These pathways regulate innate and adaptive immunity, cell death (pyroptosis), cytokine expression, and the resolution or persistence of inflammation, which is central to diseases such as autoimmunity, cancer, and atherosclerosis. Note: For structured information, entries like "NF-κB" or "NLRP3 inflammasome" are canonical targets with specific molecular details. “Inflammatory response pathway modulation” is a functional/process category, not a single molecule, and thus should be mapped to lists of pathway components and not to a single target entity.

Other names

inflammatory signalinginflammation pathway modulationmodulation of inflammatory pathways

- Inhibition of transcription factors (NF-κB, AP-1, STAT family) - Blockade of inflammasome activation (NLRP3, caspase-1 inhibitors) - Modulation of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) - Disruption of protein-protein signaling interactions (PKCδ-MAL-cJun, MAL-cJun-Gefitinib)